Seller record · Telehealth service

RX Bella

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The program and peptide pages refer only to partner compounding pharmacies in the United States, and the footer and the terms to state-licensed compounding pharmacies. 1 more criterion also fails; see the table below.

At a glance

RX BellaTelehealth service

6/8criteria passed

Price: Semaglutide from $249 a month, tirzepatide from $299
Sells: semaglutide injection, tirzepatide injection, GLP-1 microdose, and 5 more
FDA letters: None on file

Visit RX Bella See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Wyoming-based telehealth platform selling compounded semaglutide and tirzepatide injections, a lower-dose GLP-1 microdose program and a daily oral GLP-1, along with peptide therapies including tesamorelin, sermorelin, PT-141 and NAD+. Care starts with an online assessment, and the partner compounding pharmacy is not named.

Operating entity RX Web Meds LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	RX Bella's semaglutide product page; RX Bella's peptides page; RX Bella's website
S2	Prescription gating	PASS	RX Bella's website; RX Bella's about page; RX Bella's terms
S3	Pharmacy identification	FAIL	RX Bella's semaglutide product page; RX Bella's tesamorelin product page; RX Bella's terms
S4	Compounding disclosure	PASS	RX Bella's website; RX Bella's peptides page
S5	Analytical documentation	FAIL	RX Bella's peptides page; RX Bella's terms; RX Bella's HIPAA page
S6	Business address	PASS	RX Bella's contact page; RX Bella's privacy page; RX Bella's terms
S7	Price disclosure	PASS	RX Bella's peptides page; RX Bella's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews and authorizes each consultation, and treatment is prescribed only when the provider decides it is appropriate; the footer says every consultation, evaluation and prescription decision is made by independent licensed practitioners.Source: RX Bella's semaglutide product page; RX Bella's peptides page; RX Bella's website.

S2PASSThe answers on the home page say care begins with a short online assessment of health goals and medical history that a licensed clinician reviews, and the home and about pages say nothing is charged to a buyer who is not approved. The terms say no prescription product can be obtained without a completed consultation.Source: RX Bella's website; RX Bella's about page; RX Bella's terms.

S3FAILNo filling pharmacy is named. The program and peptide pages refer only to partner compounding pharmacies in the United States, and the footer and the terms to state-licensed compounding pharmacies.Source: RX Bella's semaglutide product page; RX Bella's tesamorelin product page; RX Bella's terms.

S4PASSThe disclaimer at the foot of every page and the note beneath the peptides price list state that compounded medications are not FDA-approved, and the home page adds that compounded semaglutide and tirzepatide are not the same as the branded medications.Source: RX Bella's website; RX Bella's peptides page.

S5FAILNo certificate of analysis or lot document is published on the program pages, the peptide pages, the terms, the privacy policy or the HIPAA notice.Source: RX Bella's peptides page; RX Bella's terms; RX Bella's HIPAA page.

S6PASSRX Web Meds LLC at 1309 Coffeen Avenue, STE 1200, Sheridan, WY 82801, printed as the clinic address on the contact page and as the mailing address in the privacy policy and the terms. The terms name Delaware law.Source: RX Bella's contact page; RX Bella's privacy page; RX Bella's terms.

S7PASSThe semaglutide injection from $249 a month, the tirzepatide injection from $299, the GLP-1 microdose from $199 and the oral GLP-1 from $229 a month. Tesamorelin from $299, sermorelin and PT-141 from $249 and NAD+ from $159 a month. The home page banner presents GLP-1 weight loss from $199 a month as a new patient offer, and the program pages print no figure.Source: RX Bella's peptides page; RX Bella's website.

S8PASSNo FDA warning letter names RX Bella or RX Web Meds LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection, tirzepatide injection, GLP-1 microdose, GLP-1 oral, tesamorelin, sermorelin, NAD+, PT-141.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells PT-141 Who sells tesamorelin

Visit RX Bella

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.